5 Best Micro-Cap Dividend Stocks To Buy Now

In this article, we will take a look at the 5 Best Micro-Cap Dividend Stocks To Buy Now. For deeper discussion and analysis, read 12 Best Micro-Cap Dividend Stocks To Buy Now. 

Photo by Dan Dennis on Unsplash

5. Embecta Corp. (NYSE:EMBC)

Market Cap as of May 13: $191.3 Million

On May 12, S&P Global Ratings lowered its issuer credit rating on Embecta Corp. (NYSE:EMBC) to ‘B’ from ‘B+’. The agency pointed to weaker operating performance, increasing competitive pressure, and softer-than-expected fiscal 2026 guidance. It also downgraded the company’s senior secured notes.

S&P Global Ratings said Embecta’s fiscal second-quarter 2026 revenue declined 14%. The drop was mainly tied to weaker demand for pen needles, which remain the company’s core product. The agency also noted that Embecta lost market share to a lower-cost competitor at one of its major customers.

According to the ratings firm, revenue is expected to remain under pressure over the next several years because of continued demand weakness and pricing erosion. The agency also said Embecta’s updated 2026 revenue and operating margin guidance came in below its earlier expectations. S&P Global Ratings believes this could push adjusted leverage above 4x this year, moving beyond its ratings threshold.

Despite the downgrade, the stable outlook reflects expectations that the company will keep leverage below 5x over the next couple of years as it continues using a portion of its free cash flow to reduce debt.

Embecta Corp. (NYSE:EMBC) is a global medical device company focused on improving the health and well-being of people living with diabetes. Its product portfolio includes pen needles, syringes, and safety injection devices.